Rich and diverse
Our numbers speak volumes. With more than 120 biologics in R&D and 40 products in clinical development, we have one of the strongest, most robust pipelines in the industry.
Cardiovascular and Metabolic diseases
LCM Projects - Oncology
Together with AstraZeneca, we have an exciting and balanced pipeline underpinned by great science. Uniquely positioned with both large and small molecules, the development pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development.